Anpario (LON:ANP) Price Target Increased to GBX 370 by Analysts at Canaccord Genuity Group

Anpario (LON:ANP) had its price objective upped by Canaccord Genuity Group from GBX 340 ($4.49) to GBX 370 ($4.89) in a research report released on Wednesday morning, MarketBeat reports. Canaccord Genuity Group currently has a buy rating on the stock.

Separately, Shore Capital reissued a house stock rating on shares of Anpario in a research note on Wednesday, September 11th.

Anpario Trading Up 0.3 %

LON ANP opened at GBX 313.50 ($4.14) on Wednesday. The firm has a 50 day simple moving average of GBX 289.45 and a 200-day simple moving average of GBX 273.40. The company has a debt-to-equity ratio of 0.23, a quick ratio of 5.16 and a current ratio of 5.13. Anpario has a one year low of GBX 220 ($2.91) and a one year high of GBX 340 ($4.49). The firm has a market cap of £53.01 million, a price-to-earnings ratio of 1,736.11 and a beta of 0.57.

Anpario Cuts Dividend

The company also recently announced a dividend, which will be paid on Friday, November 29th. Investors of record on Thursday, November 14th will be issued a GBX 3.25 ($0.04) dividend. The ex-dividend date is Thursday, November 14th. This represents a yield of 1.19%. Anpario’s dividend payout ratio (DPR) is 6,111.11%.

About Anpario

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.